DHC Q4 did not meet the FFO target; investors should pay special attention.

Diversified Healthcare (DHC), a medical real estate company, just announced its Q4 2025 results with numbers below expectations. The quarterly FFO per share was only $0.09, significantly lower than Zacks’ consensus estimate of $0.12. This figure is also worse than the same period in 2024 when FFO was $0.02. This indicates a negative variance of up to -25%, especially since the previous quarter DHC also faced similar difficulties with a -50% variance.

Revenue also missed expectations, but the FFO trend is key

In addition to the FFO, DHC’s revenue for the quarter ending December 2025 was $379.57 million, down 4.53% from the consensus estimate. Compared to the same period last year ($379.62 million), revenue was nearly unchanged. However, the FFO metric remains the most important indicator for real estate investment funds like DHC, as it reflects actual cash flow from operations. Over the past four quarters, DHC has only exceeded consensus FFO estimates once, indicating instability.

DHC’s stock has risen 28.7% since the start of 2026, outperforming the 0.9% increase of the S&P 500. However, uncertainty surrounding the recent numbers and future FFO outlook will be key factors influencing short-term stock price movements.

Adjusted estimates and Zacks Rank: critical factors for stock price

Deep analysis shows a strong correlation between changes in FFO estimates and short-term stock price volatility. The trend of estimate revisions for DHC before this earnings release was mixed, but after the announcement, the stock’s Zacks Rank has shifted to #3 (Hold). This suggests the stock is expected to move in line with the market rather than outperform.

Zacks Rank is based on the strength of estimate revisions, and investors can monitor this or use it as a decision-making tool. Previously, stocks with a Zacks Rank #1 (Strong Buy) demonstrated significantly better performance.

Next FFO outlook and industry context

The current consensus estimate for the next quarter is $0.14 per share on projected revenue of $395.44 million. For the full fiscal year 2026, FFO is forecasted at $0.57 per share on revenue of $1.61 billion. These figures will serve as important benchmarks to assess whether DHC can perform better in upcoming quarters.

An important factor to consider is the outlook for the healthcare REIT industry, which also has a significant impact. According to Zacks Industry Rank, the REIT and Equity Trust - Other sector ranks in the bottom 35% of over 250 industries. Studies show that top-ranked industries tend to outperform those ranked lower by about 2 times.

Compared to RLJ Lodging (RLJ), another hotel REIT, which is expected to report FFO of around $0.28 per share this quarter (down 15.2% YoY) with estimated revenue of $323.02 million. Recent estimates for RLJ have remained unchanged, indicating the market has priced the company quite stably.

Investors tracking DHC should actively monitor changes in next quarter’s FFO estimates, as this will be the most reliable measure to evaluate the company’s recovery potential.